National Vaccine Injury Compensation Program; List of Petitions Received, 78093-78095 [2014-30402]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 248 / Monday, December 29, 2014 / Notices
event before, test your connection at
https://collaboration.fda.gov/common/
help/en/support/meeting_test.htm. To
get a quick overview of the Connect Pro
program, visit https://www.adobe.com/
go/connectpro_overview. (FDA has
verified the Web site addresses in this
document, but FDA is not responsible
for any subsequent changes to the Web
sites after this document publishes in
the Federal Register.)
Comments: FDA is holding this public
workshop to obtain feedback from the
community on the questions in the
discussion paper. In order to permit the
widest possible opportunity to obtain
public comment, FDA is soliciting
either electronic or written comments
on all aspects of the public workshop
topics. The deadline for submitting
comments related to this public
workshop is March 20, 2015.
Regardless of attendance at the public
workshop, interested persons may
submit either electronic comments
regarding this document to https://
www.regulations.gov or written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. It is only
necessary to send one set of comments.
Identify comments with the docket
number found in brackets in the
heading of this document. In addition,
when responding to specific questions
as outlined in section II, please identify
the question you are addressing.
Received comments may be seen in the
Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday, and will be posted to
the docket at https://
www.regulations.gov.
Transcripts: Please be advised that as
soon as a transcript is available, it will
be accessible at https://
www.regulations.gov. It may be viewed
at the Division of Dockets Management
(see Comments). A transcript will also
be available in either hardcopy or on
CD–ROM, after submission of a
Freedom of Information request. Written
requests are to be sent to the Division
of Freedom of Information (ELEM–
1029), Food and Drug Administration,
12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857. A link to the
transcripts will also be available
approximately 45 days after the public
workshop on the Internet at https://
www.fda.gov/MedicalDevices/
NewsEvents/WorkshopsConferences/
default.htm. (Select this public
workshop from the posted events list).
I. Background
In vitro diagnostic devices, including
laboratory-developed tests that utilize
VerDate Sep<11>2014
19:09 Dec 24, 2014
Jkt 235001
NGS technology to generate information
on an individual’s genome, are rapidly
transforming healthcare. Because NGS
tests generate large amounts of data and
consequently may have relatively broad
or undefined intended uses or
indications, these tests pose certain
challenges during review of premarket
submissions. At the same time, this
large amount of data provides
opportunities for novel approaches to
assure the analytical and clinical
validity of NGS tests. FDA is committed
to providing efficient and effective
oversight for NGS tests to assure their
safety and effectiveness. By doing so,
FDA will promote innovation and
advance precision medicine. The
Agency is therefore requesting public
input on the regulatory strategy for NGS
tests that produce results on variation in
the human genome. Further details of
current and new approaches that may be
considered in the workshop are outlined
in the discussion paper entitled
‘‘Optimizing FDA’s Regulatory
Oversight of Next Generation
Sequencing Diagnostic Tests’’ available
at https://www.fda.gov/MedicalDevices/
NewsEvents/WorkshopsConferences/
default.htm. (Select this public
workshop from the posted events list).
II. Topics for Discussion at the Public
Workshop
The workshop discussion will focus
on regulatory strategies to assure the
analytical and clinical validity of NGS
tests. Specific topics to be discussed at
the workshop are outlined in the
discussion paper entitled ‘‘Optimizing
FDA’s Regulatory Oversight of Next
Generation Sequencing Diagnostic
Tests’’ available at https://www.fda.gov/
MedicalDevices/NewsEvents/
WorkshopsConferences/default.htm.
(Select this public workshop from the
posted events list). A detailed agenda
will be posted on this Web site in
advance of the workshop.
Dated: December 22, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014–30308 Filed 12–22–14; 4:15 pm]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Vaccine Injury Compensation
Program; List of Petitions Received
Health Resources and Services
Administration, HHS.
AGENCY:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
ACTION:
78093
Notice.
The Health Resources and
Services Administration (HRSA) is
publishing this notice of petitions
received under the National Vaccine
Injury Compensation Program (the
Program), as required by Section
2112(b)(2) of the Public Health Service
(PHS) Act, as amended. While the
Secretary of Health and Human Services
is named as the respondent in all
proceedings brought by the filing of
petitions for compensation under the
Program, the United States Court of
Federal Claims is charged by statute
with responsibility for considering and
acting upon the petitions.
FOR FURTHER INFORMATION CONTACT: For
information about requirements for
filing petitions, and the Program in
general, contact the Clerk, United States
Court of Federal Claims, 717 Madison
Place NW., Washington, DC 20005,
(202) 357–6400. For information on
HRSA’s role in the Program, contact the
Director, National Vaccine Injury
Compensation Program, 5600 Fishers
Lane, Room 11C–26, Rockville, MD
20857; (301) 443–6593.
SUPPLEMENTARY INFORMATION: The
Program provides a system of no-fault
compensation for certain individuals
who have been injured by specified
childhood vaccines. Subtitle 2 of Title
XXI of the PHS Act, 42 U.S.C. 300aa–
10 et seq., provides that those seeking
compensation are to file a petition with
the U.S. Court of Federal Claims and to
serve a copy of the petition on the
Secretary of Health and Human
Services, who is named as the
respondent in each proceeding. The
Secretary has delegated this
responsibility under the Program to
HRSA. The Court is directed by statute
to appoint special masters who take
evidence, conduct hearings as
appropriate, and make initial decisions
as to eligibility for and amount of
compensation.
A petition may be filed with respect
to injuries, disabilities, illnesses,
conditions, and deaths resulting from
vaccines described in the Vaccine Injury
Table (the Table) set forth at Section
2114 of the PHS Act or as set forth at
42 CFR 100.3, as applicable. This Table
lists for each covered childhood vaccine
the conditions which may lead to
compensation and, for each condition,
the time period for occurrence of the
first symptom or manifestation of onset
or of significant aggravation after
vaccine administration. Compensation
may also be awarded for conditions not
listed in the Table and for conditions
that are manifested outside the time
periods specified in the Table, but only
SUMMARY:
E:\FR\FM\29DEN1.SGM
29DEN1
tkelley on DSK3SPTVN1PROD with NOTICES
78094
Federal Register / Vol. 79, No. 248 / Monday, December 29, 2014 / Notices
if the petitioner shows that the
condition was caused by one of the
listed vaccines.
Section 2112(b)(2) of the PHS Act, 42
U.S.C. 300aa–12(b)(2), requires that
‘‘[w]ithin 30 days after the Secretary
receives service of any petition filed
under section 2111 the Secretary shall
publish notice of such petition in the
Federal Register.’’ Set forth below is a
list of petitions received by HRSA on
November 1, 2014, through November
30, 2014. This list provides the name of
petitioner, city, and state of vaccination
(if unknown then city and state of
person or attorney filing claim), and
case number. In cases where the Court
has redacted the name of a petitioner
and/or the case number, the list reflects
such redaction.
Section 2112(b)(2) also provides that
the special master ‘‘shall afford all
interested persons an opportunity to
submit relevant, written information’’
relating to the following:
1. The existence of evidence ‘‘that
there is not a preponderance of the
evidence that the illness, disability,
injury, condition, or death described in
the petition is due to factors unrelated
to the administration of the vaccine
described in the petition,’’ and
2. Any allegation in a petition that the
petitioner either:
(a) ‘‘Sustained, or had significantly
aggravated, any illness, disability,
injury, or condition not set forth in the
Vaccine Injury Table but which was
caused by’’ one of the vaccines referred
to in the Table, or
(b) ‘‘Sustained, or had significantly
aggravated, any illness, disability,
injury, or condition set forth in the
Vaccine Injury Table the first symptom
or manifestation of the onset or
significant aggravation of which did not
occur within the time period set forth in
the Table but which was caused by a
vaccine’’ referred to in the Table.
In accordance with Section
2112(b)(2), all interested persons may
submit written information relevant to
the issues described above in the case of
the petitions listed below. Any person
choosing to do so should file an original
and three (3) copies of the information
with the Clerk of the U.S. Court of
Federal Claims at the address listed
above (under the heading FOR FURTHER
INFORMATION CONTACT), with a copy to
HRSA addressed to Director, Division of
Injury Compensation Programs,
Healthcare Systems Bureau, 5600
Fishers Lane, Room 11C–26, Rockville,
MD 20857. The Court’s caption
(Petitioner’s Name v. Secretary of Health
and Human Services) and the docket
number assigned to the petition should
be used as the caption for the written
VerDate Sep<11>2014
19:09 Dec 24, 2014
Jkt 235001
submission. Chapter 35 of title 44,
United States Code, related to
paperwork reduction, does not apply to
information required for purposes of
carrying out the Program.
Dated: December 17, 2014.
Mary K. Wakefield,
Administrator.
List of Petitions Filed
1. Candi Gonzalez on behalf of Marley
Alecia-Sapphire Morales, Linwood,
New Jersey, Court of Federal Claims
No: 14–1072V.
2. Rosemary West, Walnut Creek,
California, Court of Federal Claims
No: 14–1073V.
3. Michael Smith, Kalispell, Montana,
Court of Federal Claims No: 14–
1074V.
4. Karen Comeiro, Boston,
Massachusetts, Court of Federal
Claims No: 14–1075V.
5. Louis Mansolillo, Providence, Rhode
Island, Court of Federal Claims No:
14–1080V.
6. Donald Weiss, Rossford, Ohio, Court
of Federal Claims No: 14–1081V.
7. Lynn Henderson, Lafayette, Indiana,
Court of Federal Claims No: 14–
1082V.
8. Marilyn Witbrodt, Palm Harbor,
Florida, Court of Federal Claims No:
14–1086V.
9. Martha Scrantom, Hillsborough,
North Carolina, Court of Federal
Claims No: 14–1087V.
10. Stephanie Stout on behalf of Z. S.,
Louisville, Kentucky, Court of
Federal Claims No: 14–1088V.
11. Howard McCosh, Provo, Utah, Court
of Federal Claims No: 14–1089V.
12. Virgil Kim, Bothell, Washington,
Court of Federal Claims No: 14–
1090V.
13. Natalee Hessell, Troy, Michigan,
Court of Federal Claims No: 14–
1091V.
14. Jasmine Morgan on behalf of C. S.,
Deceased, Roanoke, Virginia, Court
of Federal Claims No: 14–1094V.
15. Kristen Walter, Mt. Holly, New
Jersey, Court of Federal Claims No:
14–1095V.
16. Milford B. Reiman, Wellesley Hills,
Massachusetts, Court of Federal
Claims No: 14–1096V.
17. Janice Steinkamp, Lincoln,
Nebraska, Court of Federal Claims
No: 14–1097V.
18. Jeffrey Edgar, Marblehead,
Massachusetts, Court of Federal
Claims No: 14–1098V.
19. Nicholas J. Xanthopoulos, St. Paul,
Minnesota, Court of Federal Claims
No: 14–1101V.
20. Kayla Nichols and Jason Nichols on
behalf of Noah Nichols, Phoenix,
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Arizona, Court of Federal Claims
No: 14–1103V.
21. Kristina Ries on behalf of Nickolas
Ries, Deceased, Phoenix, Arizona,
Court of Federal Claims No: 14–
1104V.
22. Noemi Frette on behalf of N. F.,
Scottsdale, Arizona, Court of
Federal Claims No: 14–1105V.
23. Kathi Aho, St. Cloud, Minnesota,
Court of Federal Claims No: 14–
1106V.
24. Matthew Smith and Michelle Smith
on behalf of M. S., Chicago, Illinois,
Court of Federal Claims No: 14–
1107V.
25. Suzanne Fuhri on behalf of Thomas
Fic, Chicago, Illinois, Court of
Federal Claims No: 14–1108V.
26. Purvi Desai-Leyva, Albany, New
York, Court of Federal Claims No:
14–1109V.
27. Olga Molina, San Antonio, Texas,
Court of Federal Claims No: 14–
1110V.
28. Eula Jane Matthews, Cleburne,
Texas, Court of Federal Claims No:
14–1111V.
29. Ashley Puroll on behalf of P. H.,
Muskegon, Michigan, Court of
Federal Claims No: 14–1112V.
30. Paul Judge, Glen Rock, New Jersey,
Court of Federal Claims No: 14–
1113V.
31. Antoinette McCormick, College
Station, Texas, Court of Federal
Claims No: 14–1114V.
32. Daniel E. McKinney, Berkeley
Heights, New Jersey, Court of
Federal Claims No: 14–1116V.
33. Robin McCarthy-Stancavage on
behalf of A. S., Severna Park,
Maryland, Court of Federal Claims
No: 14–1117V.
34. Cornell Yellen, Souderton,
Pennsylvania, Court of Federal
Claims No: 14–1118V.
35. Eva Cruz and Omar Lopez Jiminez
on behalf of L. J. L., Deceased, Las
Vegas, Nevada, Court of Federal
Claims No: 14–1119V.
36. Elmer D. McKercher, Duluth,
Minnesota, Court of Federal Claims
No: 14–1124V.
37. Barbara Goforth, Farmville, Virginia,
Court of Federal Claims No: 14–
1128V.
38. Teresa Bray, Green Bay, Wisconsin,
Court of Federal Claims No: 14–
1131V.
39. Judith Rosenfield, Sherman Oaks,
California, Court of Federal Claims
No: 14–1132V.
40. Jose Guadalupe Garcia, II, Pasadena,
Texas, Court of Federal Claims No:
14–1136V.
41. Robert Handeyside, Saginaw,
Michigan, Court of Federal Claims
No: 14–1137V.
E:\FR\FM\29DEN1.SGM
29DEN1
Federal Register / Vol. 79, No. 248 / Monday, December 29, 2014 / Notices
42. Marlie Dulaurier, M.D., Columbus,
Ohio, Court of Federal Claims No:
14–1138V.
43. Larry Thompson, Lynchburg,
Virginia, Court of Federal Claims
No: 14–1139V.
44. Richard Greenslade, Ann Arbor,
Michigan, Court of Federal Claims
No: 14–1140V.
45. Navid Nourani, Tempe, Arizona,
Court of Federal Claims No: 14–
1142V.
46. Andrew Funk, Tempe, Arizona,
Court of Federal Claims No: 14–
1143V.
47. Duke Duquette, Uxbridge,
Massachusetts, Court of Federal
Claims No: 14–1144V.
48. Candace Johnson, Portland, Oregon,
Court of Federal Claims No: 14–
1145V.
49. Thalia Monsha Stallworth Lewis on
behalf of Alton Jerome Lewis,
Deceased, Birmingham, Alabama,
Court of Federal Claims No: 14–
1147V.
50. Billy Whitchurch, Dallas, Texas,
Court of Federal Claims No: 14–
1148V.
51. Andrea Gasaway, Dallas, Tennessee,
Court of Federal Claims No: 14–
1149V.
52. Barbara Budgake, Rahway, New
Jersey, Court of Federal Claims No:
14–1150V.
53. Douglas A. Dinunzio, Charlotte,
North Carolina, Court of Federal
Claims No: 14–1151V.
54. Imogene B. Fowler, Tuscaloosa,
Alabama, Court of Federal Claims
No: 14–1152V.
55. Mary Daniels, Boston,
Massachusetts, Court of Federal
Claims No: 14–1153V.
56. Amy Junker, Frederick, Maryland,
Court of Federal Claims No: 14–
1155V.
57. Paula Pasquinelli, Carnegie,
Pennsylvania, Court of Federal
Claims No: 14–1156V.
[FR Doc. 2014–30402 Filed 12–24–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
tkelley on DSK3SPTVN1PROD with NOTICES
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate Sep<11>2014
19:09 Dec 24, 2014
Jkt 235001
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cell Biology
Integrated Review Group; Nuclear and
Cytoplasmic Structure/Function and
Dynamics Study Section.
Date: January 29–30, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: David Balasundaram,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892, 301–435–
1022, balasundaramd@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Psychosocial Risk and Disease Prevention
Study Section.
Date: January 29–30, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Villa Florence Hotel, 225 Powell
Street, San Francisco, CA 94102,
Contact Person: Stacey FitzSimmons,
Ph.D., MPH, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7808, Bethesda, MD 20892, (301) 451–
9956, fitzsimmonss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Psychosocial Risk and Disease Prevention.
Date: January 29, 2015.
Time: 10:30 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Villa Florence Hotel, 225 Powell
Street, San Francisco, CA 94102.
Contact Person: Kristen Prentice, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, (301) 496–
0726, prenticekj@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 13–374
Modeling of Social Behavior.
Date: January 29, 2015.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jacinta Bronte-Tinkew,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892, (301) 806–
0009, brontetinkewjm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
78095
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846-93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 19, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–30257 Filed 12–24–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Correction for National
Institute of Neurological Disorders and
Stroke, Interagency Pain Research
Coordinating Committee Call for
Committee Membership Nominations
The National Institutes of Health
(NIH) is correcting a notice previously
published in the Federal Register on
December 15, 2014 (79 FR 74102) and
titled ‘‘National Institute of Neurological
Disorders and Stroke, Interagency Pain
Research Coordinating Committee Call
for Committee Membership
Nominations.’’ The notice announced
that The Department of Health and
Human Services (HHS) is seeking
nominations for the Interagency Pain
Research Coordinating Committee.
NIH is amending the due date for
nominations from January 5, 2015, as
stated toward the end of the notice, to
January 12, 2015. For further
information about the meeting, please
contact Linda Porter, Ph.D., porterl@
ninds.nih.gov.
Dated: December 16, 2014.
Walter J. Koroshetz,
Acting Director, National Institute of
Neurological Disorders and Stroke, National
Institutes of Health.
[FR Doc. 2014–30387 Filed 12–24–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
35). To request a copy of these
E:\FR\FM\29DEN1.SGM
29DEN1
]]>Agencies
[Federal Register Volume 79, Number 248 (Monday, December 29, 2014)]
[Notices]
[Pages 78093-78095]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-30402]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
National Vaccine Injury Compensation Program; List of Petitions
Received
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Health Resources and Services Administration (HRSA) is
publishing this notice of petitions received under the National Vaccine
Injury Compensation Program (the Program), as required by Section
2112(b)(2) of the Public Health Service (PHS) Act, as amended. While
the Secretary of Health and Human Services is named as the respondent
in all proceedings brought by the filing of petitions for compensation
under the Program, the United States Court of Federal Claims is charged
by statute with responsibility for considering and acting upon the
petitions.
FOR FURTHER INFORMATION CONTACT: For information about requirements for
filing petitions, and the Program in general, contact the Clerk, United
States Court of Federal Claims, 717 Madison Place NW., Washington, DC
20005, (202) 357-6400. For information on HRSA's role in the Program,
contact the Director, National Vaccine Injury Compensation Program,
5600 Fishers Lane, Room 11C-26, Rockville, MD 20857; (301) 443-6593.
SUPPLEMENTARY INFORMATION: The Program provides a system of no-fault
compensation for certain individuals who have been injured by specified
childhood vaccines. Subtitle 2 of Title XXI of the PHS Act, 42 U.S.C.
300aa-10 et seq., provides that those seeking compensation are to file
a petition with the U.S. Court of Federal Claims and to serve a copy of
the petition on the Secretary of Health and Human Services, who is
named as the respondent in each proceeding. The Secretary has delegated
this responsibility under the Program to HRSA. The Court is directed by
statute to appoint special masters who take evidence, conduct hearings
as appropriate, and make initial decisions as to eligibility for and
amount of compensation.
A petition may be filed with respect to injuries, disabilities,
illnesses, conditions, and deaths resulting from vaccines described in
the Vaccine Injury Table (the Table) set forth at Section 2114 of the
PHS Act or as set forth at 42 CFR 100.3, as applicable. This Table
lists for each covered childhood vaccine the conditions which may lead
to compensation and, for each condition, the time period for occurrence
of the first symptom or manifestation of onset or of significant
aggravation after vaccine administration. Compensation may also be
awarded for conditions not listed in the Table and for conditions that
are manifested outside the time periods specified in the Table, but
only
[[Page 78094]]
if the petitioner shows that the condition was caused by one of the
listed vaccines.
Section 2112(b)(2) of the PHS Act, 42 U.S.C. 300aa-12(b)(2),
requires that ``[w]ithin 30 days after the Secretary receives service
of any petition filed under section 2111 the Secretary shall publish
notice of such petition in the Federal Register.'' Set forth below is a
list of petitions received by HRSA on November 1, 2014, through
November 30, 2014. This list provides the name of petitioner, city, and
state of vaccination (if unknown then city and state of person or
attorney filing claim), and case number. In cases where the Court has
redacted the name of a petitioner and/or the case number, the list
reflects such redaction.
Section 2112(b)(2) also provides that the special master ``shall
afford all interested persons an opportunity to submit relevant,
written information'' relating to the following:
1. The existence of evidence ``that there is not a preponderance of
the evidence that the illness, disability, injury, condition, or death
described in the petition is due to factors unrelated to the
administration of the vaccine described in the petition,'' and
2. Any allegation in a petition that the petitioner either:
(a) ``Sustained, or had significantly aggravated, any illness,
disability, injury, or condition not set forth in the Vaccine Injury
Table but which was caused by'' one of the vaccines referred to in the
Table, or
(b) ``Sustained, or had significantly aggravated, any illness,
disability, injury, or condition set forth in the Vaccine Injury Table
the first symptom or manifestation of the onset or significant
aggravation of which did not occur within the time period set forth in
the Table but which was caused by a vaccine'' referred to in the Table.
In accordance with Section 2112(b)(2), all interested persons may
submit written information relevant to the issues described above in
the case of the petitions listed below. Any person choosing to do so
should file an original and three (3) copies of the information with
the Clerk of the U.S. Court of Federal Claims at the address listed
above (under the heading FOR FURTHER INFORMATION CONTACT), with a copy
to HRSA addressed to Director, Division of Injury Compensation
Programs, Healthcare Systems Bureau, 5600 Fishers Lane, Room 11C-26,
Rockville, MD 20857. The Court's caption (Petitioner's Name v.
Secretary of Health and Human Services) and the docket number assigned
to the petition should be used as the caption for the written
submission. Chapter 35 of title 44, United States Code, related to
paperwork reduction, does not apply to information required for
purposes of carrying out the Program.
Dated: December 17, 2014.
Mary K. Wakefield,
Administrator.
List of Petitions Filed
1. Candi Gonzalez on behalf of Marley Alecia-Sapphire Morales, Linwood,
New Jersey, Court of Federal Claims No: 14-1072V.
2. Rosemary West, Walnut Creek, California, Court of Federal Claims No:
14-1073V.
3. Michael Smith, Kalispell, Montana, Court of Federal Claims No: 14-
1074V.
4. Karen Comeiro, Boston, Massachusetts, Court of Federal Claims No:
14-1075V.
5. Louis Mansolillo, Providence, Rhode Island, Court of Federal Claims
No: 14-1080V.
6. Donald Weiss, Rossford, Ohio, Court of Federal Claims No: 14-1081V.
7. Lynn Henderson, Lafayette, Indiana, Court of Federal Claims No: 14-
1082V.
8. Marilyn Witbrodt, Palm Harbor, Florida, Court of Federal Claims No:
14-1086V.
9. Martha Scrantom, Hillsborough, North Carolina, Court of Federal
Claims No: 14-1087V.
10. Stephanie Stout on behalf of Z. S., Louisville, Kentucky, Court of
Federal Claims No: 14-1088V.
11. Howard McCosh, Provo, Utah, Court of Federal Claims No: 14-1089V.
12. Virgil Kim, Bothell, Washington, Court of Federal Claims No: 14-
1090V.
13. Natalee Hessell, Troy, Michigan, Court of Federal Claims No: 14-
1091V.
14. Jasmine Morgan on behalf of C. S., Deceased, Roanoke, Virginia,
Court of Federal Claims No: 14-1094V.
15. Kristen Walter, Mt. Holly, New Jersey, Court of Federal Claims No:
14-1095V.
16. Milford B. Reiman, Wellesley Hills, Massachusetts, Court of Federal
Claims No: 14-1096V.
17. Janice Steinkamp, Lincoln, Nebraska, Court of Federal Claims No:
14-1097V.
18. Jeffrey Edgar, Marblehead, Massachusetts, Court of Federal Claims
No: 14-1098V.
19. Nicholas J. Xanthopoulos, St. Paul, Minnesota, Court of Federal
Claims No: 14-1101V.
20. Kayla Nichols and Jason Nichols on behalf of Noah Nichols, Phoenix,
Arizona, Court of Federal Claims No: 14-1103V.
21. Kristina Ries on behalf of Nickolas Ries, Deceased, Phoenix,
Arizona, Court of Federal Claims No: 14-1104V.
22. Noemi Frette on behalf of N. F., Scottsdale, Arizona, Court of
Federal Claims No: 14-1105V.
23. Kathi Aho, St. Cloud, Minnesota, Court of Federal Claims No: 14-
1106V.
24. Matthew Smith and Michelle Smith on behalf of M. S., Chicago,
Illinois, Court of Federal Claims No: 14-1107V.
25. Suzanne Fuhri on behalf of Thomas Fic, Chicago, Illinois, Court of
Federal Claims No: 14-1108V.
26. Purvi Desai-Leyva, Albany, New York, Court of Federal Claims No:
14-1109V.
27. Olga Molina, San Antonio, Texas, Court of Federal Claims No: 14-
1110V.
28. Eula Jane Matthews, Cleburne, Texas, Court of Federal Claims No:
14-1111V.
29. Ashley Puroll on behalf of P. H., Muskegon, Michigan, Court of
Federal Claims No: 14-1112V.
30. Paul Judge, Glen Rock, New Jersey, Court of Federal Claims No: 14-
1113V.
31. Antoinette McCormick, College Station, Texas, Court of Federal
Claims No: 14-1114V.
32. Daniel E. McKinney, Berkeley Heights, New Jersey, Court of Federal
Claims No: 14-1116V.
33. Robin McCarthy-Stancavage on behalf of A. S., Severna Park,
Maryland, Court of Federal Claims No: 14-1117V.
34. Cornell Yellen, Souderton, Pennsylvania, Court of Federal Claims
No: 14-1118V.
35. Eva Cruz and Omar Lopez Jiminez on behalf of L. J. L., Deceased,
Las Vegas, Nevada, Court of Federal Claims No: 14-1119V.
36. Elmer D. McKercher, Duluth, Minnesota, Court of Federal Claims No:
14-1124V.
37. Barbara Goforth, Farmville, Virginia, Court of Federal Claims No:
14-1128V.
38. Teresa Bray, Green Bay, Wisconsin, Court of Federal Claims No: 14-
1131V.
39. Judith Rosenfield, Sherman Oaks, California, Court of Federal
Claims No: 14-1132V.
40. Jose Guadalupe Garcia, II, Pasadena, Texas, Court of Federal Claims
No: 14-1136V.
41. Robert Handeyside, Saginaw, Michigan, Court of Federal Claims No:
14-1137V.
[[Page 78095]]
42. Marlie Dulaurier, M.D., Columbus, Ohio, Court of Federal Claims No:
14-1138V.
43. Larry Thompson, Lynchburg, Virginia, Court of Federal Claims No:
14-1139V.
44. Richard Greenslade, Ann Arbor, Michigan, Court of Federal Claims
No: 14-1140V.
45. Navid Nourani, Tempe, Arizona, Court of Federal Claims No: 14-
1142V.
46. Andrew Funk, Tempe, Arizona, Court of Federal Claims No: 14-1143V.
47. Duke Duquette, Uxbridge, Massachusetts, Court of Federal Claims No:
14-1144V.
48. Candace Johnson, Portland, Oregon, Court of Federal Claims No: 14-
1145V.
49. Thalia Monsha Stallworth Lewis on behalf of Alton Jerome Lewis,
Deceased, Birmingham, Alabama, Court of Federal Claims No: 14-1147V.
50. Billy Whitchurch, Dallas, Texas, Court of Federal Claims No: 14-
1148V.
51. Andrea Gasaway, Dallas, Tennessee, Court of Federal Claims No: 14-
1149V.
52. Barbara Budgake, Rahway, New Jersey, Court of Federal Claims No:
14-1150V.
53. Douglas A. Dinunzio, Charlotte, North Carolina, Court of Federal
Claims No: 14-1151V.
54. Imogene B. Fowler, Tuscaloosa, Alabama, Court of Federal Claims No:
14-1152V.
55. Mary Daniels, Boston, Massachusetts, Court of Federal Claims No:
14-1153V.
56. Amy Junker, Frederick, Maryland, Court of Federal Claims No: 14-
1155V.
57. Paula Pasquinelli, Carnegie, Pennsylvania, Court of Federal Claims
No: 14-1156V.
[FR Doc. 2014-30402 Filed 12-24-14; 8:45 am]
BILLING CODE 4165-15-P
